Dishman Carbogen Amcis Limited

Overview

Dishman Carbogen Amcis Limited is a global outsourcing partner for pharmaceutical companies offering a portfolio of integrated, multiservice contract development and manufacturing services (CDMO) across the drug lifecycle. The company operates as a public entity and is focused on high-potency development projects and niche market therapeutics.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Dishman Carbogen Amcis Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Dishman Carbogen Amcis Limited holds 12 active (23 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CETRIMIDEActive2020-11-02
• INDIGOTINDISULFONATE SODIUM USPActive2018-06-14
• DIACETONE FRUCTOSEActive2018-05-23
• BUPIVACAINEActive2017-12-22
• ISOSULFAN BLUEActive2016-12-06
• SODIUM PICOSULFATEActive2013-10-17
• ROPIVACAINE HYDROCHLORIDE MONOHYDRATEActive2011-11-14
• PRALIDOXIME CHLORIDEActive2008-02-04
• BUPIVACAINE HYDROCHLORIDEActive2007-10-18
• BISACODYLActive2007-04-24
• CETYLPYRIDINIUM CHLORIDEActive2007-03-16
• EPROSARTAN MESYLATEActive2005-03-07
• CHOLECALCIFEROL USPInactive2019-12-17
• LEVOBUPIVACAINEInactive2019-08-20
• CHLORHEXIDINE GLUCONATE SOLUTIONInactive2018-10-21

Showing 15 of 23 Drug Master Files.

FDA compliance signals